Author:
Drolet Mélanie,Bénard Élodie,Boily Marie-Claude,Ali Hammad,Baandrup Louise,Bauer Heidi,Beddows Simon,Brisson Jacques,Brotherton Julia M L,Cummings Teresa,Donovan Basil,Fairley Christopher K,Flagg Elaine W,Johnson Anne M,Kahn Jessica A,Kavanagh Kimberley,Kjaer Susanne K,Kliewer Erich V,Lemieux-Mellouki Philippe,Markowitz Lauri,Mboup Aminata,Mesher David,Niccolai Linda,Oliphant Jeannie,Pollock Kevin G,Soldan Kate,Sonnenberg Pam,Tabrizi Sepehr N,Tanton Clare,Brisson Marc
Funder
Canadian Institutes of Health Research
Reference66 articles.
1. Performance of 21 HPV vaccination programs implemented in low and middle-income countries, 2009–2013;Ladner;BMC Public Health,2014
2. Epidemiologic classification of human papillomavirus types associated with cervical cancer;Munoz;N Engl J Med,2003
3. Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine;Garland;J Infect Dis,2009
4. Human papillomavirus vaccine introduction-the first five years;Markowitz;Vaccine,2012
5. Recommendations on the use of quadrivalent human papillomavirus vaccine in males-Advisory Committee on Immunization Practices (ACIP), 2011;MMWR Morb Mortal Wkly Rep,2011